SHINE Technologies
🇺🇸 Janesville, US · Founded 2010 · Active
SHINE Technologies is a private company in Janesville, Wisconsin, that uses fusion to make neutrons for commercial products, with fusion power as a long-term goal. It grew out of Phoenix Nuclear Labs, founded in 2005, and was spun off in 2010 to produce medical isotopes; the two were recombined in 2021. Its accelerator-driven fusion neutron sources, in which a beam of ions strikes a target, are sold for neutron testing of components for aerospace, defence and energy customers. In 2016 the Nuclear Regulatory Commission issued a construction permit for its Chrysalis medical isotope facility in Janesville, intended to produce molybdenum-99, and in 2024 it opened Cassiopeia, a lutetium-177 processing facility for cancer treatment. It is also researching recycling of used nuclear fuel.
- Sector
- Fusion, Supply chain
- Technology
- Beam-target
- Fuel
- Deuterium–tritium
- Role
- Fusion developer, Supplier
Terms
- Beam-target
- A beam of fast ions fired into a fuel target that is not itself a hot plasma, such as a gas cell or a solid loaded with deuterium or tritium. As each beam ion ploughs through the target it loses its energy to the target's electrons far faster than it is likely to fuse, so only a tiny fraction of the ions fuse before they stop. The fusion energy returned is a small fraction of the energy spent accelerating the beam, so the approach cannot reach net energy gain however the beam or target is arranged. It is commercially useful anyway, as a compact and reliable source of neutrons for imaging and medical isotope production.
- Deuterium–tritium
- Lowest ignition threshold; 80% of energy in 14.1 MeV neutrons. The reference fuel for every near-term net-gain claim.
Related companies
Sources
- SHINE Technologiesoperator
- Shine Technologiesaggregator